A 2011 report about how Kentucky’s drug courts access and use data from the state’s prescription drug monitoring program (PDMP) from the PDMP Center of Excellence at Brandeis University.
Continue reading
Resource Tag: Prescription Opioids
PBSS Data Brief: Patient Risk Measures for Controlled Substance Prescriptions in Idaho, 2012-2014
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify trends in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report summarizes the data from Idaho’s PDMP. Continue reading
PBSS Issue Brief: Geographic Patterns in Neonatal Abstinence Syndrome and Prescription Opioids in Kentucky
The Prescription Behavior Surveillance System (PBSS) collects deindentified data from state prescription drug monitoring programs (PDMPs) to identify treads in controlled substance prescribing and dispensing and indicators of non-medical use and diversion. This 2016 report looks at the Continue reading
![](https://www.opioidlibrary.org/wp-content/uploads/2019/08/Collection3.png)
Rethink Rx Abuse Strategy 5: Enhance Assessment and Referral to Substance Use Disorder Treatment
Part of Arizona’s Rethink Rx Abuse public health information campaign, these materials are intended to help communities improve patient assessment and referral to substance use disorder treatment. Includes information about medication assisted treatment for opioid use disorder, screening, brief intervention and referral to treatment (SBIRT), fact sheets on identifying opioid use disorder (OUD) or people at risk for developing OUD, and a guide to finding behavioral health treatment services.
![](https://www.opioidlibrary.org/wp-content/uploads/2019/08/Collection3.png)
Rethink Rx Abuse Strategy 4: Increase Public Awareness and Patient Education about Rx Drug Misuse and Abuse
Part of Arizona’s Rethink Rx Abuse public health information campaign, these materials are intended to help communities implement a program increase public awareness and patient education about prescription drug misuse and abuse. Includes posters aimed at youth, a guide for stigma reduction, and a guide to using medicine safely.
![](https://www.opioidlibrary.org/wp-content/uploads/2019/08/Collection3.png)
Rethink Rx Abuse Strategy 2: Promote Responsible Prescribing and Dispensing Policies and Practices
Part of Arizona’s Rethink Rx Abuse public health information campaign, these materials are intended to help communities implement a program to promote responsible prescribing and dispensing policies and practices.
![](https://www.opioidlibrary.org/wp-content/uploads/2019/08/Collection3.png)
Rethink Rx Abuse Strategy 1: Reduce Illicit Acquisition and Diversion of Prescription Drugs
Part of Arizona’s Rethink Rx Abuse public health information campaign, these materials are intended to help communities implement a program to reduce illicit acquisition and diversion of prescription drugs.
The Arizona Rx Drug Misuse and Abuse Initiative: A Multi-Systemic, Multi-Level Approach for Addressing Arizona’s “Silent Epidemic”
Arizona piloted a multi-faceted initiative intended to reduce prescription drug misuse and abuse in 4 counties between July of 2012 and December 2013. This evaluation of the pilot from the Arizona Criminal Justice Commission found that the pilot delivered results including reduced Continue reading
Pharmacist Tools and Resources
A 2016 list of resources for pharmacists in Arizona to help them reduce prescription drug abuse. It includes training opportunities and information about the prescription drug monitoring database, how to subscribe to pharmacy fraud alerts, and how to prevent pharmacy robbery and burglary. Continue reading
The Arizona Opioid Epidemic Act – Protecting Individuals with Chronic Pain (Spanish)
In 2018, the Arizona Legislature passed the Arizona Opioid Epidemic Act. This one page information sheet for patients in Spanish explains how the legislation protects chronic pain patients who use opioids to treat their pain. The document clarifies that the act does not limit prescription fills Continue reading